Market Overview

Insulet Initiated At Buy, Revenues Expected To Double


Jefferies & Company has published a research report on Insulet Corporation (NASDAQ: PODD) and has initiated coverage on the company with a Buy rating.

In the report, Jefferies writes "With adoption of the OmniPod still low and next generation products on tap for 2011, Insulet is poised for substantial growth. Revenue is expected to double over the next two years."

Jefferies has also issued a $19 price target on Insulet Corporation, which closed yesterday at $13.73.


Related Articles (PODD)

View Comments and Join the Discussion!

Posted-In: insulet corporation Jefferies & CompanyAnalyst Color Initiation Analyst Ratings

Latest Ratings

TYGB of A SecuritiesUpgrades
ZIONB of A SecuritiesMaintains39.0
RFB of A SecuritiesMaintains13.0
PNCB of A SecuritiesMaintains123.0
HBANB of A SecuritiesMaintains11.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at